StockData
Axogen, Inc. logo

Axogen, Inc. (AXGN) stock

AXGNNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 11/30147% above fair value
$55.75−0.60 (-1.06%)

Close on Nov 20, 2026Market cap $3.33BP/E –Yield –

Axogen free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Axogen's free cash flow for the twelve months ending Sep 30, 2026 was $22.04M, up 559.7% year over year. For fiscal 2025 it was -$2.93M, down 304.5% from the year before. The highest annual figure on record is $1.43M in fiscal 2024.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$2.93M-304.5%
FY2024Dec 31, 2024$1.43M–
FY2023Dec 31, 2023-$19.59M–
FY2022Dec 31, 2022-$36.14M–
FY2021Dec 31, 2021-$41.22M–
FY2020Dec 31, 2020-$31.53M–
FY2019Dec 31, 2019-$24.54M–
FY2018Dec 31, 2018-$24.14M–
FY2017Dec 31, 2017-$10.34M–
FY2016Dec 31, 2016-$12.17M–
FY2015Dec 31, 2015-$13.46M–
FY2014Dec 31, 2014-$10.99M–
FY2013Dec 31, 2013-$10.62M–
FY2012Dec 31, 2012-$8.71M–
FY2011Dec 31, 2011-$7.10M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$15.14M+789.3%
Q2 FY2026Jun 30, 2026$6.33M-9.7%
Q1 FY2026Mar 31, 2026-$1.22M–
Q4 FY2025Dec 31, 2025$1.79M-77.8%
Q3 FY2025Sep 30, 2025$1.70M-48.5%
Q2 FY2025Jun 30, 2025$7.01M+115.3%
Q1 FY2025Mar 31, 2025-$13.44M–
Q4 FY2024Dec 31, 2024$8.07M–
Q3 FY2024Sep 30, 2024$3.30M–
Q2 FY2024Jun 30, 2024$3.26M–
Q1 FY2024Mar 31, 2024-$13.19M–
Q4 FY2023Dec 31, 2023-$1.67M–
Q3 FY2023Sep 30, 2023-$2.06M–
Q2 FY2023Jun 30, 2023-$4.12M–
Q1 FY2023Mar 31, 2023-$11.73M–
Q4 FY2022Dec 31, 2022-$5.26M–
Q3 FY2022Sep 30, 2022-$5.06M–
Q2 FY2022Jun 30, 2022-$9.74M–
Q1 FY2022Mar 31, 2022-$16.09M–
Q4 FY2021Dec 31, 2021-$8.68M–
Q3 FY2021Sep 30, 2021-$10.09M–
Q2 FY2021Jun 30, 2021-$8.52M–
Q1 FY2021Mar 31, 2021-$13.92M–
Q4 FY2020Dec 31, 2020-$161.00K–
Q3 FY2020Sep 30, 2020-$3.11M–
Q2 FY2020Jun 30, 2020-$15.19M–
Q1 FY2020Mar 31, 2020-$13.07M–
Q4 FY2019Dec 31, 2019-$4.32M–
Q3 FY2019Sep 30, 2019-$3.86M–
Q2 FY2019Jun 30, 2019-$7.02M–
Q1 FY2019Mar 31, 2019-$9.35M–
Q4 FY2018Dec 31, 2018-$5.21M–
Q3 FY2018Sep 30, 2018-$8.36M–
Q2 FY2018Jun 30, 2018-$4.37M–
Q1 FY2018Mar 31, 2018-$6.20M–
Q4 FY2017Dec 31, 2017-$1.54M–
Q3 FY2017Sep 30, 2017-$2.41M–
Q2 FY2017Jun 30, 2017-$2.34M–
Q1 FY2017Mar 31, 2017-$4.05M–
Q4 FY2016Dec 31, 2016-$1.77M–

More Axogen figures

See a number that looks wrong?